1. Home
  2. DTST vs NVNO Comparison

DTST vs NVNO Comparison

Compare DTST & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data Storage Corporation

DTST

Data Storage Corporation

HOLD

Current Price

$3.02

Market Cap

7.1M

Sector

Technology

ML Signal

HOLD

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$11.53

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTST
NVNO
Founded
2001
1987
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1M
6.8M
IPO Year
2012
2017

Fundamental Metrics

Financial Performance
Metric
DTST
NVNO
Price
$3.02
$11.53
Analyst Decision
Hold
Analyst Count
1
0
Target Price
N/A
N/A
AVG Volume (30 Days)
17.4K
15.0K
Earning Date
04-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
3671.43
N/A
EPS
N/A
N/A
Revenue
$1,382,929.00
$31,243.00
Revenue This Year
$25.39
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.85
$0.30
52 Week High
$5.15
$13.44

Technical Indicators

Market Signals
Indicator
DTST
NVNO
Relative Strength Index (RSI) 43.03 54.86
Support Level $2.92 $9.66
Resistance Level $3.67 $11.26
Average True Range (ATR) 0.22 0.98
MACD -0.02 0.04
Stochastic Oscillator 15.73 47.03

Price Performance

Historical Comparison
DTST
NVNO

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc and corporate segment. It generates maximum revenue from the Nexxis Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: